Company Filing History:
Years Active: 2023
Title: Michael Lochrie: Innovator in Gene Therapy
Introduction
Michael Lochrie is a prominent inventor based in Novato, California. He has made significant contributions to the field of gene therapy, particularly through his work on adeno-associated virus (AAV) capsid proteins. His innovative approach has the potential to advance therapeutic applications in various medical fields.
Latest Patents
Michael Lochrie holds 1 patent related to his invention of novel adeno-associated virus capsid proteins. This patent encompasses AAV particles that comprise a unique capsid protein, along with polynucleotides encoding these capsid proteins. The invention also details methods for creating AAV vectors that express these novel capsid proteins, highlighting their associated therapeutic uses.
Career Highlights
Lochrie is currently employed at BioMarin Pharmaceutical Inc., where he continues to develop groundbreaking technologies in gene therapy. His work is instrumental in advancing the understanding and application of AAV vectors in medical treatments.
Collaborations
Throughout his career, Michael Lochrie has collaborated with notable colleagues, including Peter Cameron Colosi and Robert Ng. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.
Conclusion
Michael Lochrie's contributions to the field of gene therapy through his innovative work on AAV capsid proteins exemplify the impact of dedicated inventors in advancing medical science. His ongoing efforts at BioMarin Pharmaceutical Inc. continue to pave the way for future breakthroughs in therapeutic applications.